Molecular Biology of the Cell click for CBE Life Science Education Page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E08-03-0239 on September 3, 2008

Vol. 19, Issue 11, 4942-4955, November 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Materials
Right arrow All Versions of this Article:
E08-03-0239v1
19/11/4942    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in Mol. Biol. Cell
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Falguières, T.
Right arrow Articles by Gruenberg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Falguières, T.
Right arrow Articles by Gruenberg, J.

In Vitro Budding of Intralumenal Vesicles into Late Endosomes Is Regulated by Alix and Tsg101

Thomas Falguières, Pierre-Philippe Luyet, Christin Bissig, Cameron C. Scott, Marie-Claire Velluz, and Jean Gruenberg

Biochemistry Department, University of Geneva, 1211 Geneva 4, Switzerland

Submitted March 5, 2008; Revised July 18, 2008; Accepted August 26, 2008
Monitoring Editor: Sandra L. Schmid

InCytes from MBC

Endosomes along the degradation pathway leading to lysosomes accumulate membranes in their lumen and thus exhibit a characteristic multivesicular appearance. These lumenal membranes typically incorporate down-regulated EGF receptor destined for degradation, but the mechanisms that control their formation remain poorly characterized. Here, we describe a novel quantitative biochemical assay that reconstitutes the formation of lumenal vesicles within late endosomes in vitro. Vesicle budding into the endosome lumen was time-, temperature-, pH-, and energy-dependent and required cytosolic factors and endosome membrane components. Our light and electron microscopy analysis showed that the compartment supporting the budding process was accessible to endocytosed bulk tracers and EGF receptor. We also found that the EGF receptor became protected against trypsin in our assay, indicating that it was sorted into the intraendosomal vesicles that were formed in vitro. Our data show that the formation of intralumenal vesicles is ESCRT-dependent, because the process was inhibited by the K173Q dominant negative mutant of hVps4. Moreover, we find that the ESCRT-I subunit Tsg101 and its partner Alix control intralumenal vesicle formation, by acting as positive and negative regulators, respectively. We conclude that budding of the limiting membrane toward the late endosome lumen, which leads to the formation of intraendosomal vesicles, is controlled by the positive and negative functions of Tsg101 and Alix, respectively.


This was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E08-03-0239) on September 3, 2008.

Address correspondence to: Jean Gruenberg (jean.gruenberg{at}biochem.unige.ch).

Abbreviations used: Alix, ALG-2 interacting protein X; DPX, p-xylène-bis-pyridinium bromide; EGF, epidermal growth factor; ESCRT, endosomal sorting complex required for transport; HPTS, 8-hydroxypyrene-1,3,6-trisulfonic acid; HRP, horseradish peroxidase; Hrs, hepatocyte growth factor–regulated tyrosine kinase substrate; LBPA, lysobisphosphatidic acid; PNS, postnuclear supernatant; PtdIns3P, phosphatidyl-inositol-3-phosphate; siRNA, small interfering RNA; Tsg101, tumor susceptibility gene 101.


Related articles in Mol. Biol. Cell:

InCytes from MBC, November 2008

Mol. Biol. Cell 2008 19: 4545. [PDF]  



This article has been cited by other articles:


Home page
J. Virol.Home page
S. Popov, E. Popova, M. Inoue, and H. G. Gottlinger
Divergent Bro1 Domains Share the Capacity To Bind Human Immunodeficiency Virus Type 1 Nucleocapsid and To Enhance Virus-Like Particle Production
J. Virol., July 15, 2009; 83(14): 7185 - 7193.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2008 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.